Kintor Pharmaceutical Ltd (HK:9939)
:9939
Want to see HK:9939 full AI Analyst Report?
Total Valuation
Kintor Pharmaceutical Ltd has a market cap or net worth of HK$1.33B. The enterprise value is HK$1.13B.
Market CapHK$1.33B
Enterprise ValueHK$1.13B
Share Statistics
Kintor Pharmaceutical Ltd has 498,660,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding498,660,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kintor Pharmaceutical Ltd’s return on equity (ROE) is -1.10 and return on invested capital (ROIC) is -66.82%.
Return on Equity (ROE)-1.10
Return on Assets (ROA)-0.59
Return on Invested Capital (ROIC)-66.82%
Return on Capital Employed (ROCE)-0.94
Revenue Per Employee194.54K
Profits Per Employee-1.16M
Employee Count168
Asset Turnover0.10
Inventory Turnover2.04
Valuation Ratios
The current PE Ratio of Kintor Pharmaceutical Ltd is ―. Kintor Pharmaceutical Ltd’s PEG ratio is -0.18.
PE Ratio―
PS Ratio24.23
PB Ratio4.33
Price to Fair Value4.33
Price to FCF-4.77
Price to Operating Cash Flow-6.06
PEG Ratio-0.18
Income Statement
In the last 12 months, Kintor Pharmaceutical Ltd had revenue of 32.68M and earned -200.11M in profits. Earnings per share was -0.44.
Revenue32.68M
Gross Profit8.04M
Operating Income-199.78M
Pretax Income-202.96M
Net Income-200.11M
EBITDA-140.66M
Earnings Per Share (EPS)-0.44
Cash Flow
In the last 12 months, operating cash flow was -174.51M and capital expenditures -830.01K, giving a free cash flow of -175.34M billion.
Operating Cash Flow-174.51M
Free Cash Flow-175.34M
Free Cash Flow per Share-0.35
Dividends & Yields
Kintor Pharmaceutical Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.48
52-Week Price Change88.57%
50-Day Moving Average3.00
200-Day Moving Average2.46
Relative Strength Index (RSI)42.06
Average Volume (3m)4.99M
Important Dates
Kintor Pharmaceutical Ltd upcoming earnings date is Aug 31, 2026, TBA (Confirmed).
Last Earnings DateMar 30, 2026
Next Earnings DateAug 31, 2026
Ex-Dividend Date―
Financial Position
Kintor Pharmaceutical Ltd as a current ratio of 0.43, with Debt / Equity ratio of 47.43%
Current Ratio0.43
Quick Ratio0.34
Debt to Market Cap0.11
Net Debt to EBITDA-0.37
Interest Coverage Ratio-52.00
Taxes
In the past 12 months, Kintor Pharmaceutical Ltd has paid 2.85M in taxes.
Income Tax2.85M
Effective Tax Rate-0.01
Enterprise Valuation
Kintor Pharmaceutical Ltd EV to EBITDA ratio is -6.00, with an EV/FCF ratio of -5.08.
EV to Sales25.81
EV to EBITDA-6.00
EV to Free Cash Flow-5.08
EV to Operating Cash Flow-5.10
Balance Sheet
Kintor Pharmaceutical Ltd has HK$34.78M in cash and marketable securities with HK$86.64M in debt, giving a net cash position of -HK$51.85M billion.
Cash & Marketable SecuritiesHK$34.78M
Total DebtHK$86.64M
Net Cash-HK$51.85M
Net Cash Per Share-HK$0.10
Tangible Book Value Per ShareHK$0.17
Margins
Gross margin is 24.60%, with operating margin of -611.29%, and net profit margin of -612.29%.
Gross Margin24.60%
Operating Margin-611.29%
Pretax Margin-621.01%
Net Profit Margin-612.29%
EBITDA Margin-430.37%
EBIT Margin-527.63%
Analyst Forecast
The average price target for Kintor Pharmaceutical Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast557.36%
EPS Growth Forecast-24.06%